Related Experiment Video

Updated: Jun 15, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Absence of association between CD86 +1057G/A polymorphism and coronary artery disease

Xiao-Na Ma1, Xia Wang, You-Yi Yan

  • 1West China School of Preclinical and Forensic Medicine, West China Second University Hospital, Sichuan University, Chengdu, PR China.

DNA and Cell Biology
|March 17, 2010
PubMed

Insights

This study found no link between the CD86 +1057G/A gene variant and coronary artery disease (CAD) risk in the Chinese population. Further research is needed to explore other genetic factors in CAD development.

Area of Science:

  • Immunology
  • Cardiovascular Disease Genetics

Background:

  • CD86 is a crucial costimulatory molecule in T-cell immunity.
  • CD86 also plays a role in the pathogenesis of cardiovascular diseases.

Purpose of the Study:

  • To investigate the association between CD86 gene polymorphism and coronary artery disease (CAD) risk.
  • Focus on the CD86 +1057G/A (rs1129055) single-nucleotide polymorphism in a Chinese population.

Main Methods:

  • Genotyping of CD86 +1057G/A polymorphism using polymerase chain reaction-restriction fragment length polymorphism.
  • DNA sequencing assay for confirmation.
  • Case-control study involving 164 CAD patients and 299 healthy controls.

Main Results:

  • No significant difference in genotype frequencies of CD86 +1057G/A polymorphism between CAD cases and controls.
  • No significant difference in allele frequencies of CD86 +1057G/A polymorphism between CAD cases and controls.

Conclusions:

  • The CD86 +1057G/A polymorphism is unlikely to be associated with CAD risk in the studied Chinese population.
  • Genetic contributions to CAD require further investigation beyond this specific CD86 variant.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...